These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
139 related items for PubMed ID: 26354988
1. Evaluation of outcome measures for neurogenic claudication: A patient-centered approach. Markman JD, Gewandter JS, Frazer ME, Pittman C, Cai X, Patel KV, Jahromi BS, Dworkin RH, Burke LB, Farrar JT. Neurology; 2015 Oct 06; 85(14):1250-6. PubMed ID: 26354988 [Abstract] [Full Text] [Related]
4. Double-blind, randomized, controlled, crossover trial of pregabalin for neurogenic claudication. Markman JD, Frazer ME, Rast SA, McDermott MP, Gewandter JS, Chowdhry AK, Czerniecka K, Pilcher WH, Simon LS, Dworkin RH. Neurology; 2015 Jan 20; 84(3):265-72. PubMed ID: 25503625 [Abstract] [Full Text] [Related]
5. Degenerative spondylolisthesis in patients with neurogenic claudication effects functional performance and self-reported quality of life. Drury T, Ames SE, Costi K, Beynnon B, Hall J. Spine (Phila Pa 1976); 2009 Dec 01; 34(25):2812-7. PubMed ID: 19940740 [Abstract] [Full Text] [Related]
8. Comparison of walking variations during treadmill walking test between neurogenic and vascular claudication: a crossover study. Houle M, O'Shaughnessy J, Tétreau C, Châtillon CÉ, Marchand AA, Descarreaux M. Chiropr Man Therap; 2021 Jul 15; 29(1):24. PubMed ID: 34266463 [Abstract] [Full Text] [Related]
9. Predictors of objectively measured walking capacity in people with degenerative lumbar spinal stenosis. Tomkins-Lane CC, Battié MC. J Back Musculoskelet Rehabil; 2013 Jul 15; 26(4):345-52. PubMed ID: 23948821 [Abstract] [Full Text] [Related]
10. Measurement properties of walking outcome measures for neurogenic claudication: a systematic review and meta analysis. Anderson DB, Mathieson S, Eyles J, Maher CG, Van Gelder JM, Tomkins-Lane CC, Ammendolia C, Bella V, Ferreira ML. Spine J; 2019 Aug 15; 19(8):1378-1396. PubMed ID: 30986579 [Abstract] [Full Text] [Related]
11. A comprehensive study of patients with surgically treated lumbar spinal stenosis with neurogenic claudication. Yukawa Y, Lenke LG, Tenhula J, Bridwell KH, Riew KD, Blanke K. J Bone Joint Surg Am; 2002 Nov 15; 84(11):1954-9. PubMed ID: 12429755 [Abstract] [Full Text] [Related]
12. MILD® Is an Effective Treatment for Lumbar Spinal Stenosis with Neurogenic Claudication: MiDAS ENCORE Randomized Controlled Trial. Benyamin RM, Staats PS, MiDAS Encore I. Pain Physician; 2016 May 15; 19(4):229-42. PubMed ID: 27228511 [Abstract] [Full Text] [Related]
14. Objective functional assessment using the "Timed Up and Go" test in patients with lumbar spinal stenosis. Stienen MN, Maldaner N, Joswig H, Corniola MV, Bellut D, Prömmel P, Regli L, Weyerbrock A, Schaller K, Gautschi OP. Neurosurg Focus; 2019 May 01; 46(5):E4. PubMed ID: 31042663 [Abstract] [Full Text] [Related]
17. Gait analysis does not correlate with clinical and MR imaging parameters in patients with symptomatic lumbar spinal stenosis. Zeifang F, Schiltenwolf M, Abel R, Moradi B. BMC Musculoskelet Disord; 2008 Jun 20; 9():89. PubMed ID: 18570636 [Abstract] [Full Text] [Related]
18. An outcome measure of functionality in patients with lumber spinal stenosis: a validation study of the Iranian version of Neurogenic Claudication Outcome Score (NCOS). Azimi P, Mohammadi HR, Montazeri A. BMC Neurol; 2012 Sep 24; 12():101. PubMed ID: 23006983 [Abstract] [Full Text] [Related]